IT201700113648A1 - Anti-BAG3 antibodies as therapeutic reagent in cardiovascular diseases - Google Patents

Anti-BAG3 antibodies as therapeutic reagent in cardiovascular diseases

Info

Publication number
IT201700113648A1
IT201700113648A1 IT102017000113648A IT201700113648A IT201700113648A1 IT 201700113648 A1 IT201700113648 A1 IT 201700113648A1 IT 102017000113648 A IT102017000113648 A IT 102017000113648A IT 201700113648 A IT201700113648 A IT 201700113648A IT 201700113648 A1 IT201700113648 A1 IT 201700113648A1
Authority
IT
Italy
Prior art keywords
cardiovascular diseases
therapeutic reagent
bag3 antibodies
bag3
antibodies
Prior art date
Application number
IT102017000113648A
Other languages
Italian (it)
Inventor
Maria Caterina Turco
Liberato Marzullo
Alessandra Rosati
Marco Margot De
Anna Basile
Original Assignee
Biouniversa Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biouniversa Srl filed Critical Biouniversa Srl
Priority to IT102017000113648A priority Critical patent/IT201700113648A1/en
Priority to US17/040,468 priority patent/US20210024623A1/en
Priority to EP18743531.8A priority patent/EP3658582A1/en
Priority to PCT/EP2018/070259 priority patent/WO2019020734A1/en
Priority to CA3107625A priority patent/CA3107625A1/en
Publication of IT201700113648A1 publication Critical patent/IT201700113648A1/en
Priority to US17/703,747 priority patent/US20220213182A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
IT102017000113648A 2017-07-28 2017-10-10 Anti-BAG3 antibodies as therapeutic reagent in cardiovascular diseases IT201700113648A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT102017000113648A IT201700113648A1 (en) 2017-10-10 2017-10-10 Anti-BAG3 antibodies as therapeutic reagent in cardiovascular diseases
US17/040,468 US20210024623A1 (en) 2017-07-28 2018-07-26 Anti-bag3 antibodies as therapeutic reagent in cardiovascular disease
EP18743531.8A EP3658582A1 (en) 2017-07-28 2018-07-26 Anti-bag3 antibodies as therapeutic reagent in cardiovascular diseases
PCT/EP2018/070259 WO2019020734A1 (en) 2017-07-28 2018-07-26 Anti-bag3 antibodies as therapeutic reagent in cardiovascular diseases
CA3107625A CA3107625A1 (en) 2017-07-28 2018-07-26 Anti-bag3 antibodies as therapeutic reagent in cardiovascular diseases
US17/703,747 US20220213182A1 (en) 2017-07-28 2022-03-24 Anti-bag3 antibodies as therapeutic reagent in cardiovascular disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102017000113648A IT201700113648A1 (en) 2017-10-10 2017-10-10 Anti-BAG3 antibodies as therapeutic reagent in cardiovascular diseases

Publications (1)

Publication Number Publication Date
IT201700113648A1 true IT201700113648A1 (en) 2019-04-10

Family

ID=61024993

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102017000113648A IT201700113648A1 (en) 2017-07-28 2017-10-10 Anti-BAG3 antibodies as therapeutic reagent in cardiovascular diseases

Country Status (1)

Country Link
IT (1) IT201700113648A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011067377A1 (en) * 2009-12-04 2011-06-09 Biouniversa S.R.L. Biochemical serum marker
WO2015117010A2 (en) * 2014-01-31 2015-08-06 Temple University Of The Commonwealth System Of Higher Education Bag3 as a target for therapy of heart failure
WO2017031182A2 (en) * 2015-08-17 2017-02-23 Temple University Of The Commonwealth System Of Higher Education Bag3 compositions and methods

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011067377A1 (en) * 2009-12-04 2011-06-09 Biouniversa S.R.L. Biochemical serum marker
WO2015117010A2 (en) * 2014-01-31 2015-08-06 Temple University Of The Commonwealth System Of Higher Education Bag3 as a target for therapy of heart failure
WO2017031182A2 (en) * 2015-08-17 2017-02-23 Temple University Of The Commonwealth System Of Higher Education Bag3 compositions and methods

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ALBINO CARRIZZO ET AL: "The prosurvival protein BAG3: a new participant in vascular homeostasis", CELL DEATH AND DISEASE, vol. 7, no. 10, 20 October 2016 (2016-10-20), pages e2431, XP055366731, DOI: 10.1038/cddis.2016.321 *
M DE MARCO ET AL: "Detection of soluble BAG3 and anti-BAG3 antibodies in patients with chronic heart failure", CELL DEATH DIS, vol. 4, no. 2, 14 February 2013 (2013-02-14), pages e495, XP055087188, DOI: 10.1038/cddis.2013.8 *

Similar Documents

Publication Publication Date Title
IL290496A (en) Therapeutic antibodies and their uses
ZA201804326B (en) Therapeutic cd47 antibodies
KR102355950B9 (en) Antibodies to TIGIT
MA45004A (en) ANTI-WT1-HLA SPECIFIC ANTIBODIES
MA42626A (en) NEW ANTI-PD-1 ANTIBODIES
DK3344654T3 (en) ANTI-LAG-3 ANTIBODIES
KR20180084817A (en) Anti-SIGLEC-9 antibodies and methods of using the same
MA53297A (en) ANTI-ICOS ANTIBODIES
MA47472A (en) ANTIBODY
DK3333191T3 (en) Anti-C10ORF54 antibodies and uses thereof
DK3126388T3 (en) Anti-EGFRvIII antibodies and uses thereof
DK3350218T3 (en) POLYOMAVIRUS-NEUTRALIZING ANTIBODIES
MA50352A (en) MULTISPECIFIC ANTIBODIES
DK3242892T3 (en) MODIFIED APRIL BINDING ANTIBODIES
DK3606961T3 (en) GARP-TGF-BETA ANTIBODIES
MA43738A (en) ANTI-TNFALPHA ANTIBODIES AND THEIR FUNCTIONAL FRAGMENTS
DK3250593T3 (en) ANTI-TRANSTHYRETIN ANTIBODIES
MA42843A (en) ANTI-CD115 ANTIBODY
MA51554A (en) IMPROVED IL-6 ANTIBODIES
HK1247091A1 (en) Therapeutic antibodies and uses thereof
MA49250A (en) NEW ANTI-CD3 ANTIBODIES
MA43715A (en) ANTI-TNF ANTIBODIES AND CORRESPONDING FUNCTIONAL FRAGMENTS
KR20180085008A (en) Anti-PCSK9 antibodies and uses thereof
MA50654A (en) ANTI-PACAP ANTIBODIES
DK3484921T3 (en) Anti-IL-22R antibodies